BG63394B1 - Производни на кондензирани 2,3-бензодиазепини и използването им като инхибитори на амра-рецептори - Google Patents

Производни на кондензирани 2,3-бензодиазепини и използването им като инхибитори на амра-рецептори Download PDF

Info

Publication number
BG63394B1
BG63394B1 BG102658A BG10265898A BG63394B1 BG 63394 B1 BG63394 B1 BG 63394B1 BG 102658 A BG102658 A BG 102658A BG 10265898 A BG10265898 A BG 10265898A BG 63394 B1 BG63394 B1 BG 63394B1
Authority
BG
Bulgaria
Prior art keywords
benzodiazepine
imidazo
dioxolo
aminophenyl
methoxy
Prior art date
Application number
BG102658A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102658A (en
Inventor
Ernese Csuzdi
Tamas Hamori
Gizella Abraham
Sandor Solyom
Istvan Tarnava
Pal Berzsenyi
Ferenc Andrasi
Istvan Ling
Antal SIMAI
Melinda Gal
Katalin Horvath
Eszter Szentkuti
Marta Szollosy
Istvan Pallagi
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7785064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG63394(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of BG102658A publication Critical patent/BG102658A/xx
Publication of BG63394B1 publication Critical patent/BG63394B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG102658A 1996-02-01 1998-07-29 Производни на кондензирани 2,3-бензодиазепини и използването им като инхибитори на амра-рецептори BG63394B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19604919A DE19604919A1 (de) 1996-02-01 1996-02-01 Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
PCT/DE1997/000234 WO1997028163A1 (de) 1996-02-01 1997-01-29 Kondensierte 2,3-benzodiazepin derivate und deren verwendung als ampa-rezeptoren-hemmer

Publications (2)

Publication Number Publication Date
BG102658A BG102658A (en) 1999-06-30
BG63394B1 true BG63394B1 (bg) 2001-12-29

Family

ID=7785064

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102658A BG63394B1 (bg) 1996-02-01 1998-07-29 Производни на кондензирани 2,3-бензодиазепини и използването им като инхибитори на амра-рецептори

Country Status (31)

Country Link
US (2) US6323197B1 (cs)
EP (1) EP0888356B1 (cs)
JP (1) JP4141499B2 (cs)
KR (1) KR100465269B1 (cs)
CN (1) CN1096464C (cs)
AT (1) ATE214703T1 (cs)
AU (1) AU724956B2 (cs)
BG (1) BG63394B1 (cs)
BR (1) BR9707335A (cs)
CA (1) CA2245539C (cs)
CZ (1) CZ289658B6 (cs)
DE (2) DE19604919A1 (cs)
DK (1) DK0888356T3 (cs)
EE (1) EE04017B1 (cs)
ES (1) ES2173435T3 (cs)
HK (1) HK1018782A1 (cs)
HU (1) HU224636B1 (cs)
IL (1) IL125480A (cs)
IS (1) IS2103B (cs)
MY (1) MY119140A (cs)
NO (1) NO983510L (cs)
NZ (1) NZ331187A (cs)
PL (1) PL187128B1 (cs)
PT (1) PT888356E (cs)
RU (1) RU2179557C2 (cs)
SK (1) SK283563B6 (cs)
TR (1) TR199801485T2 (cs)
TW (1) TW438801B (cs)
UA (1) UA56157C2 (cs)
WO (1) WO1997028163A1 (cs)
ZA (1) ZA97848B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9701325A1 (hu) 1997-07-31 2000-08-28 Gyógyszerkutató Intézet Kft. Új 2,3-benzodiazepin-származékok
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
EP1100504A2 (en) * 1998-07-02 2001-05-23 Eisai Co., Ltd. Pharmaceutical compositions and their uses for treatment of demyelinating disorders
WO2001098280A2 (en) * 2000-06-16 2001-12-27 Annovis, Inc. 5h-2,3-benzodiazepine antagonists of excitatory amino acid receptors
DE10041671C1 (de) 2000-08-10 2002-06-13 Schering Ag Verfahren zur Herstellung von Imidazo[1,2-c][2,3]benzodiazepinen sowie Phenylessigsäureester und Oxazol-Derivate als Zwischenprodukte bei deren Herstellung
US20070280876A1 (en) * 2004-03-25 2007-12-06 William Marsh Rice University Functionalization of Carbon Nanotubes in Acidic Media
US20060166969A1 (en) * 2005-01-14 2006-07-27 Turski Lechoslaw A AMPA antagonists for the treatment of dizziness, including vertigo and Meniere's disorder
EP2338492A1 (en) 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891871A (en) 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
HU9600871D0 (en) * 1996-04-04 1996-05-28 Gyogyszerkutato Intezet New 2,3-benzodiazepine derivatives

Also Published As

Publication number Publication date
EP0888356B1 (de) 2002-03-20
MY119140A (en) 2005-04-30
JP4141499B2 (ja) 2008-08-27
AU724956B2 (en) 2000-10-05
IL125480A (en) 2002-07-25
HU224636B1 (hu) 2005-12-28
ZA97848B (en) 1997-08-04
US6323197B1 (en) 2001-11-27
CN1210538A (zh) 1999-03-10
US6600036B2 (en) 2003-07-29
DK0888356T3 (da) 2002-06-03
IL125480A0 (en) 1999-03-12
SK103398A3 (en) 1999-01-11
DE19604919A1 (de) 1997-08-07
EP0888356A1 (de) 1999-01-07
KR19990082192A (ko) 1999-11-25
BR9707335A (pt) 1999-07-20
PL187128B1 (pl) 2004-05-31
IS2103B (is) 2006-05-15
EE04017B1 (et) 2003-04-15
CN1096464C (zh) 2002-12-18
HUP9901417A2 (hu) 1999-08-30
PT888356E (pt) 2002-09-30
PL328224A1 (en) 1999-01-18
IS4794A (is) 1998-07-06
DE59706686D1 (de) 2002-04-25
ATE214703T1 (de) 2002-04-15
WO1997028163A1 (de) 1997-08-07
UA56157C2 (uk) 2003-05-15
KR100465269B1 (ko) 2005-04-14
CA2245539C (en) 2005-10-04
HK1018782A1 (en) 2000-01-07
NO983510D0 (no) 1998-07-30
CZ242798A3 (cs) 1999-01-13
BG102658A (en) 1999-06-30
CA2245539A1 (en) 1997-08-07
RU2179557C2 (ru) 2002-02-20
NZ331187A (en) 2000-01-28
CZ289658B6 (cs) 2002-03-13
HUP9901417A3 (en) 2001-11-28
NO983510L (no) 1998-09-30
JP2000503997A (ja) 2000-04-04
AU2502997A (en) 1997-08-22
US20020052364A1 (en) 2002-05-02
EE9800225A (et) 1998-12-15
TW438801B (en) 2001-06-07
SK283563B6 (sk) 2003-09-11
ES2173435T3 (es) 2002-10-16
TR199801485T2 (xx) 1998-10-21

Similar Documents

Publication Publication Date Title
AU685821B2 (en) Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
KR100883003B1 (ko) 알츠하이머병의 치료를 위한 글라이신 수송체1(ｇｌｙｔ-1) 억제제로서 바이- 및 트라이사이클릭 치환된페닐 메탄온
JP2690282B2 (ja) イミダゾジアゼピン
JP2001511813A (ja) Ｃｒｆレセプターアンタゴニストおよびそれらに関連する方法
AU2004213375A1 (en) Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-Hydroxytryptamine-6 ligands
JP2004501918A (ja) Ｘａ因子阻害剤としての１−（ヘテロアリール−フェニル）−縮合ピラゾール誘導体
AU8027187A (en) 2-substituted-E-fused-(1,2,4)triazolo(1,5-C)pyrimidines pharmaceutical compositions
CA2344828A1 (en) ¬1,2,4|triazolo¬1,5-c|pyrimidine derivatives
CA2025005A1 (en) Condensed diazepinones, process for preparing them and pharmaceutical compositions containing these compounds
WO2003057161A2 (en) BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF
JPWO2005051949A1 (ja) 新規縮合イミダゾール誘導体
BG63394B1 (bg) Производни на кондензирани 2,3-бензодиазепини и използването им като инхибитори на амра-рецептори
JP2003516994A (ja) 認知能力を向上させるための置換１，２，３−トリアゾロ［１，５−ａ］キナゾリン
SK8952002A3 (en) Pyrazolo[1,5-d][1,2,4]triazine derivatives, method for their preparation, pharmaceutical composition containing them and use thereof
RU2107686C1 (ru) Производное 3-оксадиазолил-5,6,7,8-тетрагидро-1,6-нафтиридина и производное 5,6,7,8-тетрагидро-1,6-нафтиридина
WO2001003644A9 (en) Pyrazolopyrimidinone derivatives conjugated to thiophene moieties or benzo [fused] 5-membered heterocycles for erectile dysfunction
JPS59141580A (ja) インド−ル誘導体
JPH01250383A (ja) ベンゾチエピノ〔５，４−ｃ〕ピリダジン化合物